Cargando…
New Insight in Hyperinsulinism/Hyperammonemia Syndrome by Magnetic Resonance Imaging and Spectroscopy
Hyperinsulinism/hyperammonemia syndrome (HI/HA) is an autosomal dominant disorder caused by monoallelic activating mutations in the glutamate dehydrogenase 1 (GLUD1) gene. While hyperinsulinism may be explained by a reduction in the allosteric inhibition of GLUD1, the pathogenesis of HA in HI/HA rem...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946637/ https://www.ncbi.nlm.nih.gov/pubmed/35326344 http://dx.doi.org/10.3390/brainsci12030389 |
_version_ | 1784674241790083072 |
---|---|
author | Gariani, Karim Klauser, Antoine Vargas, Maria Isabel Lazeyras, François Tran, Christel |
author_facet | Gariani, Karim Klauser, Antoine Vargas, Maria Isabel Lazeyras, François Tran, Christel |
author_sort | Gariani, Karim |
collection | PubMed |
description | Hyperinsulinism/hyperammonemia syndrome (HI/HA) is an autosomal dominant disorder caused by monoallelic activating mutations in the glutamate dehydrogenase 1 (GLUD1) gene. While hyperinsulinism may be explained by a reduction in the allosteric inhibition of GLUD1, the pathogenesis of HA in HI/HA remains uncertain; interestingly, HA in the HI/HA syndrome is not associated with acute hyperammonemic intoxication events. We obtained a brain magnetic resonance (MR) in a woman with HI/HA syndrome with chronic asymptomatic HA. On MR spectroscopy, choline and myoinositol were decreased as in other HA disorders. In contrast, distinct from other HA disorders, combined glutamate and glutamine levels were normal (not increased). This observation suggests that brain biochemistry in HI/HA may differ from that of other HA disorders. In HI/HA, ammonia overproduction may come to the expense of glutamate levels, and this seems to prevent the condensation of ammonia with glutamate to produce glutamine that is typical of the other HA disorders. The absence of combined glutamate and glutamine elevation might be correlated to the absence of acute cerebral ammonia toxicity. |
format | Online Article Text |
id | pubmed-8946637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89466372022-03-25 New Insight in Hyperinsulinism/Hyperammonemia Syndrome by Magnetic Resonance Imaging and Spectroscopy Gariani, Karim Klauser, Antoine Vargas, Maria Isabel Lazeyras, François Tran, Christel Brain Sci Case Report Hyperinsulinism/hyperammonemia syndrome (HI/HA) is an autosomal dominant disorder caused by monoallelic activating mutations in the glutamate dehydrogenase 1 (GLUD1) gene. While hyperinsulinism may be explained by a reduction in the allosteric inhibition of GLUD1, the pathogenesis of HA in HI/HA remains uncertain; interestingly, HA in the HI/HA syndrome is not associated with acute hyperammonemic intoxication events. We obtained a brain magnetic resonance (MR) in a woman with HI/HA syndrome with chronic asymptomatic HA. On MR spectroscopy, choline and myoinositol were decreased as in other HA disorders. In contrast, distinct from other HA disorders, combined glutamate and glutamine levels were normal (not increased). This observation suggests that brain biochemistry in HI/HA may differ from that of other HA disorders. In HI/HA, ammonia overproduction may come to the expense of glutamate levels, and this seems to prevent the condensation of ammonia with glutamate to produce glutamine that is typical of the other HA disorders. The absence of combined glutamate and glutamine elevation might be correlated to the absence of acute cerebral ammonia toxicity. MDPI 2022-03-15 /pmc/articles/PMC8946637/ /pubmed/35326344 http://dx.doi.org/10.3390/brainsci12030389 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Gariani, Karim Klauser, Antoine Vargas, Maria Isabel Lazeyras, François Tran, Christel New Insight in Hyperinsulinism/Hyperammonemia Syndrome by Magnetic Resonance Imaging and Spectroscopy |
title | New Insight in Hyperinsulinism/Hyperammonemia Syndrome by Magnetic Resonance Imaging and Spectroscopy |
title_full | New Insight in Hyperinsulinism/Hyperammonemia Syndrome by Magnetic Resonance Imaging and Spectroscopy |
title_fullStr | New Insight in Hyperinsulinism/Hyperammonemia Syndrome by Magnetic Resonance Imaging and Spectroscopy |
title_full_unstemmed | New Insight in Hyperinsulinism/Hyperammonemia Syndrome by Magnetic Resonance Imaging and Spectroscopy |
title_short | New Insight in Hyperinsulinism/Hyperammonemia Syndrome by Magnetic Resonance Imaging and Spectroscopy |
title_sort | new insight in hyperinsulinism/hyperammonemia syndrome by magnetic resonance imaging and spectroscopy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946637/ https://www.ncbi.nlm.nih.gov/pubmed/35326344 http://dx.doi.org/10.3390/brainsci12030389 |
work_keys_str_mv | AT garianikarim newinsightinhyperinsulinismhyperammonemiasyndromebymagneticresonanceimagingandspectroscopy AT klauserantoine newinsightinhyperinsulinismhyperammonemiasyndromebymagneticresonanceimagingandspectroscopy AT vargasmariaisabel newinsightinhyperinsulinismhyperammonemiasyndromebymagneticresonanceimagingandspectroscopy AT lazeyrasfrancois newinsightinhyperinsulinismhyperammonemiasyndromebymagneticresonanceimagingandspectroscopy AT tranchristel newinsightinhyperinsulinismhyperammonemiasyndromebymagneticresonanceimagingandspectroscopy |